Survival Benefit of Intravenous Busulfan (120 Mg/M2) and Fludarabine Myeloablative Regimen for Treatment of Myeloid Malignancies

Journal of Stem Cell Research & Therapy
doi 10.4172/2157-7633.1000338
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group


Related search